McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



